Related references
Note: Only part of the references are listed.Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal Anastomosis
Lori Robbins et al.
JOURNAL OF CROHNS & COLITIS (2017)
Crohn's Disease of the Pouch: A True Diagnosis or an Oversubscribed Diagnosis of Exclusion?
Amy L. Lightner et al.
DISEASES OF THE COLON & RECTUM (2017)
Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal Anastomosis
Sharon Z. Koh et al.
INFLAMMATORY BOWEL DISEASES (2016)
Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis
Eran Zittan et al.
INFLAMMATORY BOWEL DISEASES (2016)
Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
Maria K. Magnusson et al.
JOURNAL OF CROHNS & COLITIS (2016)
Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease
David Busquets et al.
JOURNAL OF CROHNS & COLITIS (2015)
Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study
A. Gustavsson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Do preoperative factors predict subsequent diagnosis of Crohn's disease after ileal pouch-anal anastomosis for ulcerative or indeterminate colitis?
G. B. Melton et al.
COLORECTAL DISEASE (2010)
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Family History of Crohn's Disease Is Associated with an Increased Risk for Crohn's Disease of the Pouch
Bo Shen et al.
INFLAMMATORY BOWEL DISEASES (2009)
Increased Efficacy of Delayed-Release Mesalamine 4.8g/D (800mg Tablet) in Patients Previously Diagnosed with Ulcerative Colitis (UC)
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis
Gil Y. Melmed et al.
DISEASES OF THE COLON & RECTUM (2008)
Unresectable Colorectal Cancer Can Be Cured With Multimodality Therapy
Kellie L. Mathis et al.
ANNALS OF SURGERY (2008)
Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis
D. Hahnloser et al.
BRITISH JOURNAL OF SURGERY (2007)
Risk factors for diseases of heal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis
B Shen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study
G Järnerot et al.
GASTROENTEROLOGY (2005)
Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation
T Hui et al.
DISEASES OF THE COLON & RECTUM (2005)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
The fate of the heal pouch in patients developing Crohn's disease
JM Braveman et al.
DISEASES OF THE COLON & RECTUM (2004)
Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery
VW Fazio et al.
ANNALS OF SURGERY (2003)
Long-term failure after restorative proctocolectomy for ulcerative colitis
H Tulchinsky et al.
ANNALS OF SURGERY (2003)
Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis
F Alexander et al.
JOURNAL OF PEDIATRIC SURGERY (2003)
Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis
MT Dayton et al.
ARCHIVES OF SURGERY (2002)
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study
BE Sands et al.
INFLAMMATORY BOWEL DISEASES (2001)
Share Paper
